According to The Cancer Genome Atlas (TCGA) pan cancer studies (23), ATM somatic mutations are most frequently found in endometrial cancer (~18.7%), followed by bladder cancer (~12.9%) and colorectal cancer (~11.8%). This evidence concerns the gene ATM and endometrial cancer.